VF
NAVB

Virtu Financial’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Virtu Financial’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-333,069
Closed -$30K – 2269
2023
Q3 		$30K Buy
+333,069
New +$30.9K ﹤0.01% 960
2023
Q2 		– Sell
-16,301
Closed -$4K – 2431
2023
Q1 		$4K Sell
16,301
-17,353
-52% -$5.07K ﹤0.01% 1416
2022
Q4 		$7K Sell
33,654
-4,557
-12% -$1.14K ﹤0.01% 1427
2022
Q3 		$10K Buy
+38,211
New +$17.8K ﹤0.01% 1526
2022
Q2 		– Sell
-14,483
Closed -$11K – 2408
2022
Q1 		$11K Sell
14,483
-10,726
-43% -$9.83K ﹤0.01% 1360
2021
Q4 		$25K Buy
+25,209
New +$35.5K ﹤0.01% 1490
2020
Q3 		– Sell
-17,586
Closed -$69K – 1804
2020
Q2 		$69K Buy
+17,586
New +$33.6K 0.01% 956
2019
Q4 		– Sell
-19,011
Closed -$13K – 2069
2019
Q3 		$13K Sell
19,011
-45,747
-71% -$28.1K ﹤0.01% 1331
2019
Q2 		$41K Buy
64,758
+55,409
+593% +$107K ﹤0.01% 1272
2019
Q1 		$26K Buy
9,349
+4,533
+94% +$13.4K ﹤0.01% 1267
2018
Q4 		$10K Sell
4,816
-536
-10% -$2.21K ﹤0.01% 1449
2018
Q3 		$25K Buy
5,352
+3,368
+170% +$12.8K ﹤0.01% 1387
2018
Q2 		$9K Buy
1,984
+1,433
+260% +$7.5K ﹤0.01% 1909
2018
Q1 		$4K Sell
551
-267
-33% -$2K ﹤0.01% 1873
2017
Q4 		$6K Buy
818
+287
+54% +$2.43K ﹤0.01% 2283
2017
Q3 		$4K Buy
+531
New +$4.5K ﹤0.01% 2445

Other funds holding NAVB

BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

Virtu Financial's NAVB Position: Q4 2023 in Review

Virtu Financial sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2023, closing a stake of 333,069 shares — an estimated $30K sold.

Virtu Financial first reported a position in NAVB in Q3 2017 and held it in 16 quarters. The position peaked at $69K in Q2 2020. 4 funds tracked by Wall St. Rank hold NAVB as of Q4 2023.

  • Virtu Financial reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2023 after selling out during the quarter.
  • Virtu Financial sold 333,069 Navidea Biopharmaceuticals Inc. shares in Q4 2023, an estimated $30K.
  • Virtu Financial first reported a position in Navidea Biopharmaceuticals Inc. in Q3 2017 and held it in 16 quarters.
  • Virtu Financial's Navidea Biopharmaceuticals Inc. position peaked at $69K in Q2 2020.
  • 4 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.